EME (psychedelic)

EME (psychedelic)

EME or 3,4-Ethylenedioxy-N-methylamphetamine is a psychedelic drug and a substituted amphetamine. It is structurally related to MDMA and is part of the phenethylamine family. EME is known for its psychoactive properties and is classified as a Schedule I drug under the Controlled Substances Act in the United States.

Chemistry

EME is a ring-substituted derivative of methamphetamine. It is chemically classified as a phenethylamine and a substituted amphetamine. The compound features a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl group at Rα.

Pharmacology

The pharmacological mechanisms of EME are not fully understood. However, it is believed to work primarily as a serotonin-norepinephrine-dopamine releasing agent (SNDRA). This means it increases the levels of these neurotransmitters in the brain by binding to and partially blocking their transporter proteins.

Effects

The effects of EME are similar to those of other psychedelic drugs. Users may experience alterations in consciousness, perception, and mood. Other effects can include visual hallucinations, euphoria, increased empathy, and heightened sensory perception.

Risks

As with all psychedelic drugs, EME carries risks. These can include psychological dependence, neurotoxicity, and severe adverse reactions. It is important to note that the use of EME is illegal in many jurisdictions, and possession can lead to criminal charges.

See also

• MDMA
• Psychedelic drug
• Substituted amphetamine
• Controlled Substances Act

References

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

•